106
Participants
Start Date
March 15, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
June 30, 2016
Hydromorphone (Standardized, weight-based dosing)
Standardized analgesic management using a SCD specific standard protocol based on NHBLI guidelines (initial opioid dose weight-based).
Morphine Sulfate (Standardized, weight-based dosing)
Standardized analgesic management using a SCD specific standard protocol based on NHBLI guidelines (initial opioid dose weight-based).
Hydromorphone (Patient Specific dosing)
Patient specific analgesic management, with specific opioid dosage and frequency based on a protocol developed by a patient's healthcare team.
Morphine Sulfate (Patient Specific dosing)
Patient specific analgesic management, with specific opioid dosage and frequency based on a protocol developed by a patient's healthcare team.
Mount Sinai Hospital, New York
University of Cincinnati Medical Center, Cincinnati
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Cincinnati
OTHER
Mount Sinai Hospital, New York
OTHER
Duke University
OTHER